New Key Statistics Module, Z-Score and F-Score
OTCPK:RPHCF Key Ratios
Market Cap $ M | 5,293.83 |
Enterprise Value $ M | 4,767.74 |
P/E(ttm) | 26.33 |
PE Ratio without NRI | 25.38 |
Forward PE Ratio | 20.59 |
Price/Book | 3.23 |
Price/Sales | 2.87 |
Price/Free Cash Flow | 31.52 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.20 |
Revenue (TTM) $ M | 1,858.00 |
EPS (TTM) $ | 0.89 |
Beneish M-Score | -2.39 |
10-y EBITDA Growth Rate % | 9.50 |
5-y EBITDA Growth Rate % | 16.30 |
y-y EBITDA Growth Rate % | 19.00 |
EV-to-EBIT | 17.25 |
EV-to-EBITDA | 17.25 |
PEG | 1.56 |
Shares Outstanding M | 228.14 |
Net Margin (%) | 10.91 |
Operating Margin % | 14.59 |
Pre-tax Margin (%) | 14.88 |
Quick Ratio | 1.93 |
Current Ratio | 2.47 |
ROA % (ttm) | 9.18 |
ROE % (ttm) | 13.20 |
ROIC % (ttm) | 13.34 |
Dividend Yield % | -- |
Altman Z-Score | 7.29 |
RPHCF Number of Guru Trades
RPHCF Volume of Guru Trades
Gurus Latest Trades with OTCPK:RPHCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:RPHCF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Rohto Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:RPHCF
Total 0- 1